The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.

Back

HFA Premium Access

The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor M. Tinoco (Guimaraes, PT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Mariana Tinoco

Alto Ave Hospital Center, Guimaraes (Portugal)

2 presentations

0 follower

34 more presentations in this session

Impact of socioeconomic status in medical resource use and outcomes in patients with heart failure managed in integrated care settings: a population-based pragmatic evaluation in 77,554 patients.

Speaker: Doctor J. Comin-Colet (Barcelona, ES)

Access

Abstract

Slides

Sex differences in clinical characteristics and outcomes after acute myocardial infarction: insights from PARADISE-MI

Speaker: Doctor X. Wang (Boston, US)

Access

Abstract

Slides

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Speaker: Doctor V. Donoso (Valencia, ES)

Access

Abstract

Slides

Handheld echocardiography in outpatient heart failure clinics: facilitating prompt heart failure treatment

Speaker: Doctor K. Somarakis (Leicester, GB)

Access

Abstract

Slides

Outcomes related to hyponatraemia and effects of dapagliflozin: findings from DAPA-HF

Speaker: Doctor S. Yeoh (Glasgow, GB)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 7

Speakers: Doctor M. Tinoco, Doctor J. Comin-Colet, Doctor X. Wang, Doctor V. Donoso, Doctor K. Somarakis...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources